404 related articles for article (PubMed ID: 35346813)
1. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B
ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats:
Singla R; Mishra A; Joshi R; Kumar R; Sarma P; Sharma AR; Kaur G; Bhatia A; Medhi B
ACS Chem Neurosci; 2021 May; 12(10):1749-1767. PubMed ID: 33913688
[TBL] [Abstract][Full Text] [Related]
4. Homotaurine ameliorates the core ASD symptomatology in VPA rats through GABAergic signaling: Role of GAD67.
Singla R; Mishra A; Joshi R; Sarma P; Kumar R; Kaur G; Sharma AR; Jain A; Prakash A; Bhatia A; Medhi B
Brain Res Bull; 2022 Nov; 190():122-133. PubMed ID: 36113682
[TBL] [Abstract][Full Text] [Related]
5. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
Ishola IO; Balogun AO; Adeyemi OO
Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
[TBL] [Abstract][Full Text] [Related]
6. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
Luhach K; Kulkarni GT; Singh VP; Sharma B
J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
[TBL] [Abstract][Full Text] [Related]
9. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
10. Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats.
Sandhya T; Sowjanya J; Veeresh B
Neurochem Res; 2012 May; 37(5):1121-31. PubMed ID: 22322665
[TBL] [Abstract][Full Text] [Related]
11. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
Kumar H; Sharma BM; Sharma B
Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
[TBL] [Abstract][Full Text] [Related]
12. Syringic acid alleviates valproic acid induced autism via activation of p38 mitogen-activated protein kinase: Possible molecular approach.
Mallan S; Singh S
Environ Toxicol; 2023 Oct; 38(10):2400-2415. PubMed ID: 37357844
[TBL] [Abstract][Full Text] [Related]
13. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
14. Benefits of bone marrow mesenchymal stem cells compared to their conditioned medium in valproic acid-induced autism in rats.
Noshadian M; Ragerdi Kashani I; Asadi-Golshan R; Zarini D; Ghafari N; Zahedi E; Pasbakhsh P
Mol Biol Rep; 2024 Feb; 51(1):353. PubMed ID: 38401030
[TBL] [Abstract][Full Text] [Related]
15. Effects of music on cognitive behavioral impairments in both sex of adult rats exposed prenatally to valproic acid.
Taheri F; Joushi S; Mohammadipoor-Ghasemabad L; Rad I; Esmaeilpour K; Sheibani V
Birth Defects Res; 2024 Jan; 116(1):e2300. PubMed ID: 38277409
[TBL] [Abstract][Full Text] [Related]
16. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
17. Music alleviates cognitive impairments in an animal model of autism.
Taheri F; Joushi S; Esmaeilpour K; Sheibani V; Ebrahimi MN; Taheri Zadeh Z
Int J Dev Neurosci; 2023 Aug; 83(5):399-416. PubMed ID: 37246451
[TBL] [Abstract][Full Text] [Related]
18. Fucoxanthin mitigates valproic acid-induced autistic behavior through modulation of the AKT/GSK-3β signaling pathway.
Anand P; Kaur A; Singh S
Eur J Pharmacol; 2024 Mar; 967():176335. PubMed ID: 38331341
[TBL] [Abstract][Full Text] [Related]
19. G protein-coupled estrogen receptor (GPER) selective agonist G1 attenuates the neurobehavioral, molecular and biochemical alterations induced in a valproic acid rat model of autism.
Hameed RA; Ahmed EK; Mahmoud AA; Atef AA
Life Sci; 2023 Sep; 328():121860. PubMed ID: 37331505
[TBL] [Abstract][Full Text] [Related]
20. Bacopa monniera ameliorates cognitive impairment and neurodegeneration induced by intracerebroventricular-streptozotocin in rat: behavioral, biochemical, immunohistochemical and histopathological evidences.
Khan MB; Ahmad M; Ahmad S; Ishrat T; Vaibhav K; Khuwaja G; Islam F
Metab Brain Dis; 2015 Feb; 30(1):115-27. PubMed ID: 25037167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
